to BioTechniques free email alert service to receive content updates.
Common benzothiazole and benzoxazole fluorescent DNA intercalators for studying Alzheimer Aβ1-42 and prion amyloid peptides
 
Steingrimur Stefansson1, Daniel L Adams2, and Cha-Mei Tang2
1Fuzbien Technology Institute, Rockville, MD, USA
2Creatv MicroTech, Potomac, MD, USA
BioTechniques, Vol. , No. , May 2012, pp. 1–6
Full Text (PDF)
Author Summary

In this study, we characterize the binding of six commercial benzothiazole/benzoxazole fluorescent DNA intercalating dyes from Invitrogen to Alzheimer and prion amyloid peptides. Biochemical interactions between these dyes and amyloids were assessed using thioflavin-T, Congo red, and chrysamine-G, which are established amyloid dyes. Our results indicate these dyes can be used as acceptors in thioflavin-T fluorescence resonance energy transfer and as reporter groups for competition studies with Congo red and chrysamine-G.

Abstract

Amyloids are fibrillar protein aggregates associated with a number of neurodegenerative pathologies including Alzheimer and Creutzfeldt–Jakob disease. The study of amyloids is usually based on fluorescence with the dye thioflavin-T. Although a number of amyloid binding compounds have been synthesized, many are nonfluorescent or not readily available for research use. Here we report on a class of commercial benzothiazole/benzoxazole containing fluorescent DNA intercalators from Invitrogen that possess the ability to bind amyloid Aβ1-42 peptide and hamster prion. These dyes fluoresce from 500–750 nm and are available as dimers or monomers. We demonstrate that these dyes can be used as acceptors for thioflavin-T fluorescence resonance energy transfer as well as reporter groups for binding studies with Congo red and chrysamine G. As more potential therapeutic compounds for these diseases are generated, there is a need for simple and inexpensive methods to monitor their interactions with amyloids. The fluorescent dyes reported here are readily available and can be used as tools for biochemical studies of amyloid structures and in vitro screening of potential therapeutics.

Amyloidosis includes neuropathologies such as Alzheimer, Parkinson's, Huntington's, and Creutzfeldt–Jakob disease (1, 2). Amyloidosis is also found in other apparently disparate diseases such as type 2 diabetes (3). A characteristic pathology of these diseases are deposits of proteinaceous aggregates that are resistant to normal proteolysis. These proteins are often cross-β sheet polymers, and although they do not share significant amino acid sequence similarities, the fibrils appear to share similar morphology and mechanisms of toxicity (4). X-ray diffraction, electron microscopy and solid-state nuclear magnetic resonance have shown that amyloid fibrils are long and unbranched with an organized core structure composed of either parallel or anti-parallel β-sheets (5-7).

To date, one of the most common methods to study amyloid fibrils is through the use of dyes, including Congo red and thioflavin-T (ThT). Congo red is nonfluorescent, but shows apple-green birefringence under polarized light when bound to amyloids (8). ThT is a small benzothiazole compound that is weakly fluorescent in solution, but becomes highly fluorescent when bound to amyloid, with absorption/emission maxima of 440 nm/480 nm (9). The mechanism of how these dyes bind amyloid is not fully understood, but studies suggest that ThT and Congo red orient with their long axis parallel to the long axis of the fibrils (10-12).

ThT and Congo red are not uniquely specific amyloid stains. ThT can fluorescence by binding non-β-sheet cavities, such as those in acetylcholinesterase and γ-cyclodextrin, and ThT does not bind β-sheet rich structures, such as transthyretin (11). Similarly, Congo red binds many enzymes, such as dehydrogenases, and other proteins that have a nucleotide binding site (13). However, the potential diagnostic value of identifying a specific amyloid stain prompted synthesis and study of Congo red and ThT analogs. Additionally, the search for unrelated chemicals that specifically bind amyloids has yielded many diverse compounds (14).

Despite the expanding number of amyloid binding compounds being discovered, options for studying their biochemical interactions with amyloids are still somewhat limited. This is in part due to the optical properties of many amyloid binding compounds. Most ThT/Congo red analogs and related compounds absorb light at wavelengths that overlap with endogenous protein absorption and fluorescence (15, 16). Since many of these compounds have nondistinct optical properties, in vivo and in vitro biochemical studies rely heavily on radiolabeled compounds (17-20). Although many amyloid binding dyes that fluoresce at longer wavelengths have been synthesized (21-24), most have not found their way into common usage. The reasons for this could be that many of these dyes are either not available commercially or require expertise in synthetic organic chemistry to produce. Additionally, many amyloid binding compounds have been patented.

The benzothiazole moiety of ThT is critical for binding amyloid (9). Benzothiazoles are a versatile group found in many compounds that bind both proteins and DNA and include Thiazole Orange, Stains-All, PicoGreen, and luciferin. We noticed that a well-characterized class of DNA intercalating dyes from Invitrogen is chemically similar to ThT, in that they have a benzothiazole component or the chemically related benzoxazole (Figure 1). This prompted us to examine whether this class of dyes is also able to bind amyloid peptides. Our results demonstrate that these dyes fluoresce in the presence of purified Alzheimer Aβ1–42 peptide and recombinant hamster prions. Moreover, they proved to be versatile with respect to resonance energy transfer and in competition studies with Congo red and chrysamine G. It is hoped that because of their ready availability, these dyes can be used for screening potential therapeutic drugs and increase the arsenal available to researchers studying these debilitating diseases.




Figure 1. Structures of ThT (A) and the IG dyes BOBO-1 (B), POPO-3 (C), YOYO-3 (D), and TOTO-3 (E) along with their fluorescence emission spectra in the presence of Alzheimer Aβ1–42 peptide (10–30 μg/mL). (Click to enlarge)


Materials and methods

ThT and Congo red were purchased from Sigma-Aldrich (St. Louis, MO, USA). Chrysamine G and half-chrysamine G were purchased from Anaspec (Fremont, CA, USA). Structures of Congo red, chrysamine G, and half chrysamine G can be found at http://aatbio.com/. Recombinant hamster prion protein in fibrillar β-sheet conformation expressed and purified according to (25, 26) was purchased from UMBI Medical Biotechnology Center (Baltimore, MD, USA). Synthetic Aβ1–42 peptide was purchased from rPeptide (Bogart, GA, USA). The Aβ1–42 peptide from this manufacturer has been shown by electron microscopy to form fibrils in solution (27). Glass capillary PCR tubes were purchased from Roche (Indianapolis, IN, USA). Nucleic Acid Stains Dimer Sampler kit (containing 10 μL of each dye: BOBO-1, BOBO-3, POPO-1, POPO-3, TOTO-1, TOTO-3, YOYO-1, and YOYO-3), TO-PRO-3, ethidium bromide (EthBr), and λ DNA standard were purchased from Invitrogen (Grand Island, NY, USA). All chemicals were used as received.

Fluorescence assays

Molar extinction coefficients (ε) were used to quantitate the following dyes: Chrysamine G (58,487 M-1cm-1 at 392 nm; Anaspec product info), half-chrysamine G (21,289 M-1cm-1 at 343 nm; Anaspec product info), Congo red (50,000 M-1cm-1 at 498 nm) (13), and ThT (24,420 M-1cm-1 at 420 nm) (28). Excitation/emission maxima for the Invitrogen dyes (IG dyes) provided by the manufacturer (in nm) are as follow: BOBO-1 (462/481), BOBO-3 (570/602), POPO-1 (434/456), POPO-3 (534/570), TOTO-1 (514/533), TOTO-3 (642/660), YOYO-1 (491/509), YOYO-3 (612/631), and TO-PRO-3 (642/661). Quantum yield of these fluorophores in buffer are usually less than 0.01 but increase up to 0.6 in the presence of DNA (http://probes.invitrogen.com/media/pis/mp03600.pdf).

Fluorescent assays were performed using the ultrasensitive Signalyte-II fluorometer (Creatv Microtech, Potomac, MD, USA), described in more detail in (29-31). The fluorometer used for these studies was equipped with four light-emitting diodes (LED) including red, amber, green, and blue LEDs with excitation maxima of 470, 530, 590, and 635 nm and long-pass emission filters with cut-on wavelength of 515, 570, 630, and 665 nm. TOTO-1 and POPO-1 were not used for these studies because the fluorometer used did not have the appropriate LEDs and filters. The fluorometer cuvettes are glass capillary PCR tubes. For the fluorescence measurements, dyes were mixed with protein or DNA samples at room temperature in a 96-well microtiter plate in duplicate for approximately 10 min before 40-μL aliquots were loaded into the glass tubes and measured. Concentrations of peptides used for the experiments are given in the figure legends. All fluorescent binding assays were either performed in PBS unless otherwise stated. Fluorescence was measured for up to 3 s per tube.

Results and discussion

Figure 1 shows the structures of ThT (Figure 1A) and the IG dyes BOBO-1 (Figure 1B), POPO-3 (Figure 1C), YOYO-3 (Figure 1D), and TOTO-3 (Figure 1E) along with their fluorescence emission spectra in the presence of Alzheimer Aβ1–42 peptide. Hamster prion protein also showed analogous fluorescence spectra to the Aβ peptide (data not shown). In Figure 1, the ThT emission peak appears at 521 nm instead of the reported value of 480 nm. This apparent shift in peak value appears to be an artifact due to the 515 nm cut-off filter used in the Signalyte fluorometer, but there was negligible shift in the emission of Aβ1–42, DNA, and prion with the different dyes (data not shown). Figure 1 shows the substantial structural similarities between the IG dyes and ThT. The IG dyes contain either positively charged N-methyl-benzothiazole or N-methyl-benzoxazole rings that are similar in dimension to the positively charged dimethyl benzothiazole ring of ThT. Although the IG dyes do not have an N′N-dimethylaniline moiety like ThT, they do have flat aromatic groups that can rotate independently of the benzothiazole/benzoxazole, a property that is important for the binding of ThT to amyloid (9).

The benzothiazole moiety of ThT is important for its binding to amyloids. The crystal structure of amyloid-like β2-microglobulin in complex with ThT shows that the benzothiazole moiety has a well-defined apolar binding pocket within the amyloid structure (9). Studies have also shown that chemical modification of the ThT benzothiazole moiety affects affinity for Aβ peptides (20, 32). Many other amyloid structures similarly possess a hydrophobic pocket that could accommodate benzothiazole compounds such as ThT (33). Benzothiazole compounds have also been shown to bind to huntingtin, which is associated with Huntington's disease, and inhibit its fibrillogenesis (34). Compounds containing the related benzoxazole moiety have also been shown to bind amyloids (35).

Since the IG dyes are DNA intercalators, it is possible that the observed fluorescence could be due to contaminating DNA in the recombinant peptide preparations. Therefore we compared fluorescence increase of the amyloid peptides and λ DNA standard against a panel of dyes.

Table 1 shows the increase in fluorescence observed when ThT, IG dyes, and EthBr (which is not structurally related to the aforementioned dyes) are incubated with a DNA standard, Aβ1–42 peptide, or hamster prion. On the basis of weight, the amyloid peptides show a modest increase in fluorescence compared with DNA. Other benzothiazole containing dyes have also been reported to bind both DNA and the amyloid form of β-lactoglobulin (23, 36, 37). ThT showed an increase in fluorescence upon binding to both amyloid proteins, but much less so with DNA. Conversely, EthBr showed an increase in fluorescence upon binding to DNA, but almost no increase with the amyloid peptides. Although these results do not rule out contaminating DNA in the protein preparations, they suggest that any contamination would be low. This is supported by an HPLC trace provided by rPeptide, which shows no significant peaks, besides the product (data not shown).

  1    2  



In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer.

By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Bio Techniques uses cookies please go to our Cookie Policy page.